炎症变化对类风湿关节炎患者估计十年心血管风险的影响
研究纳入前瞻性类风湿关节炎队列中相隔1年连续两次CRP变化≥10 mg/L的180例患者,用Framingham风险评分、2013年美国心脏病学会/美国心脏协会动脉粥样硬化性心血管疾病风险评分、Reynolds风险评分(RRS)和QRISK2估算10年心血管风险。仅RRS对炎症变化敏感,炎症升高与估计心血管风险升高相关(P < 0.0001),且仅RRS与proBNP变化相关(r = 0.17, P = 0.03)。
要点
- 在4种经验证的人群心血管风险计算工具中,仅RRS对类风湿关节炎患者的炎症变化敏感。
- 炎症升高与RRS估计的心血管风险升高相关(P < 0.0001)。
- 仅RRS的变化与proBNP变化相关(r = 0.17, P = 0.03)。
核心结论
- 除RRS外,使用经验证的一般人群心血管风险计算工具估计的心血管风险未见显著变化。
- 这些发现提示类风湿关节炎患者的心血管风险可能受炎症变化调节,而现有心血管风险计算工具通常未考虑这一点。
研究设计与样本
- 前瞻性类风湿关节炎队列研究,纳入相隔1年连续两次时间点CRP下降或升高≥10 mg/L的患者(分别为CRP下降组和CRP升高组)。
- 共纳入180例类风湿关节炎患者,平均年龄57.8岁,84%为女性,80%为血清阳性。
- 使用Framingham风险评分、2013年美国心脏病学会/美国心脏协会动脉粥样硬化性心血管疾病风险评分、Reynolds风险评分(RRS)和QRISK2估算10年心血管风险。
- 采用配对t检验比较基线与1年随访时的风险评分,并计算风险评分变化与pro-B型利钠肽(pro BNP)变化的相关性。
主要发现
- 在所研究的计算工具中,仅RRS对炎症变化敏感;炎症升高与估计心血管风险升高相关(P < 0.0001)。
- 仅RRS与proBNP变化相关(r = 0.17, P = 0.03)。
- 使用其他经验证的一般人群心血管风险计算工具估计的心血管风险未见显著变化。
关键数值与推荐
- RRS是所研究计算工具中唯一包含CRP水平变量的工具。
- 炎症升高与RRS估计心血管风险升高相关(P < 0.0001)。
- RRS变化与proBNP变化相关(r = 0.17, P = 0.03)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Current validated cardiovascular (CV) risk estimates were developed in populations with relatively stable levels of inflammation, whereas patients with rheumatoid arthritis (RA) routinely experience significant changes in inflammation. This study was undertaken to test whether changes in inflammation affect estimated CV risk as measured using validated population-based risk calculators. METHODS: Participants in a prospective RA cohort who experienced a decrease or an increase of ≥10 mg/liter in the C-reactive protein (CRP) level at 2 consecutive time points 1 year apart (CRP decrease group and CRP increase group, respectively) were included in this study. We estimated 10-year CV risk using the following calculators: Framingham Risk Score, 2013 American College of Cardiology/American Heart Association Atherosclerotic Cardiovascular Disease Risk Score, Reynolds Risk Score (RRS), and QRISK2. Of these calculators, only the RRS includes a variable addressing the CRP level. Paired t-tests were performed to compare risk scores at baseline and 1-year follow-up. We calculated the correlations between the changes in risk scores and changes in pro-B-type natriuretic peptide (pro BNP), a surrogate marker of CV risk. RESULTS: One hundred eighty RA patients were included in the study (mean age 57.8 years, 84% female, 80% seropositive). Of the calculators studied, only the RRS was sensitive to changes in inflammation; an increase in inflammation was associated with increased estimated CV risk (P < 0.0001), and only the RRS was correlated with changes in proBNP (r = 0.17, P = 0.03). CONCLUSION: Our data showed no significant change in CV risk estimated using validated general population CV risk calculators except for the RRS. These findings suggest that CV risk may be modulated by changes in inflammation in RA, which is not typically considered when using existing CV risk calculators.
引用
- Yu Z, Yang N, Everett BM, et al. Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis. Arthritis Rheumatol. 2018. PMID: 29676517. doi:10.1002/art.40532
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。